Heparin-induced thrombocytopenia

Stefan D. Jevtic, Andrew M. Morris, Theodore E. Warkentin, Menaka Pai

Canadian Medical Association Journal · 2021 · 63 citations · 377 references

DOIFull text

Open access

Concepts

Abstract

Heparin-induced thrombocytopenia is an uncommon condition mediated by anti-PF4 platelet-activating antibodies that typically begins 5–14 days after heparin initiation. Overall, greater risk is associated with unfractionated heparin than with low-molecular-weight heparin.[1][1] The platelet count

References

377